MoneyWorks4Me

Granules India - Quaterly Results

09 Aug 2022 Evaluate
The sales for the June 2022 quarter moved up 25.85% to Rs. 9213.57 millions as compared to Rs. 7321.16 millions during the corresponding quarter last year.Good  Net Profit growth of 38.87% reported above the corresponding previous quarter figure of Rs. 898.45 millions to Rs. 1247.68 millioins.Operating profit for the quarter ended June 2022 rose to 2012.09 millions as compared to 1573.91 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 9213.57 7321.16 25.85 9213.57 7321.16 25.85 32384.37 31349.82 3.30
Other Income 45.48 73.56 -38.17 45.48 73.56 -38.17 175.10 137.23 27.60
PBIDT 2012.09 1573.91 27.84 2012.09 1573.91 27.84 6621.59 8750.96 -24.33
Interest 44.39 53.84 -17.55 44.39 53.84 -17.55 163.52 237.74 -31.22
PBDT 1967.70 1520.07 29.45 1967.70 1520.07 29.45 6458.07 8513.22 -24.14
Depreciation 345.99 314.96 9.85 345.99 314.96 9.85 1261.61 1184.51 6.51
PBT 1621.71 1205.11 34.57 1621.71 1205.11 34.57 5196.46 7328.71 -29.09
TAX 374.03 306.66 21.97 374.03 306.66 21.97 1331.31 1800.87 -26.07
Deferred Tax -20.55 -5.31 287.01 -20.55 -5.31 287.01 -3.76 -169.74 -97.78
PAT 1247.68 898.45 38.87 1247.68 898.45 38.87 3865.15 5527.84 -30.08
Equity 248.01 247.68 0.13 248.01 247.68 0.13 248.01 247.68 0.13
PBIDTM(%) 21.84 21.50 1.58 21.84 21.50 1.58 20.45 27.91 -26.75
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..